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ABSTRACT 
Background and Objectives: Organophosphorus compound 
poisoning is the commonest medico toxic emergency in India, because of 
its easy availability. Respiratory failure is the most common complication 
of OPC poisoning leading to death. Early recognition and prompt 
ventilatory support may improve survival. Hence this study was 
undertaken to assess the severity of organophosphorus compound 
poisoning both clinically by using Peradeniya scoring and by estimating 
serum creatine phosphokinase level. 
Methods: A prospective study was conducted on 50 patients 
admitted at emergency ward of GMKMCH, Salem within 6hrs of OPC 
intoxication. Detailed history and clinical examination were done. 
Patients were evaluated for Peradeniya OPC poisoning scale and serum 
CPK was taken at the time of admission. 
Results: Age group ranged from 17-67 years. Majority of the 
patients were in the age group of 21-30 years. 66% of patients were males 
and 34% were females. Most common poison encountered is 
monocrotophos. Common signs were miosis 88%, difficulty in breathing 
76%.According to POP scale 52% were in mild grade, 40% were in 
moderate grade and 8% were in severe grade.  Study revealed significant 
elevation of serum CPK in moderate to severe grade of POP scale. 
Interpretation: Serum CPK more than 500 IU/L predicts high 
degree of suspicion of subsequent respiratory failure. Peradeniya  scoring 
more than 5  provide high degree of suspicion of subsequent respiratory 
failure.  
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INTRODUCTON 
Organophosphorus compounds are becoming one of the most 
common causes of poisoning. 
OPC were first synthesized by Schrader during the Second world 
war. OPC were first used as an agricultural insecticide and later as 
potential chemical warfare agents. Organophosphorus compounds are 
used as pesticides, herbicides, and chemical warfare agents in the form of 
nerve gases. 
WHO has estimated approximately 3 million pesticide poisoning 
occur every year and cause more than 220000 deaths. India is a 
predominantly an agrarian country with about 60 – 80 % of rural 
population. So, pesticide is an easy access for the suicidal purpose. 
Organophosphorus compounds act by irreversibly inhibiting the 
enzyme cholinesterase, resulting in accumulation of acetylcholine at 
synapse and myoneural junction leading to cholinergic over activity. 
Respiratory failure is the most common complication leading to 
death.Early recognition and prompt ventilatory support may improve 
survival. 
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Peradeniya OP poisoning scale has not been studied much in 
Indian scenario. It is a simple effective scale to determine the need for 
ventilatory support early on the course. Serum cpk is found elevated in op 
poisoning .it can be used as a biomarker in predicting the prognosis. 
Hence this study was undertaken to assess the severity OP poisoning 
using both Peradeniya scoring and by estimating serum CPK levels. 
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AIMS OF STUDY 
  
To correlate serum CPK levels and clinical parameters (Peradeniya 
op poisoning scale) to preditct the need for ventilatory support.  
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Review of literature 
 The synthesis of a highly potent compound tetraethyl 
pyrophosphate(TEPP) by phillipe de clerment in 1854 gave him the 
honour of conceiving the idea of  organophosphorous compound5.In 1932 
Lange and kreuger, discovered the biological activity of OP esters 
producing a strong cholinergic effect in human beings. In 1936-1937, 
Gerhard Schrader5, German scientist also noticed similar effects. This 
made Schrader to synthesis around 2000 compounds like parathion, 
tabun, sarin etc. The word “cholinesterase” was introduced by Stedman 
and his co-workers in 1932. Extensive research lead to find that there are 
two main type of cholinesterase. One is called acetyl cholinesterase or 
true cholinesterase. The other one is called non specific cholinesterase or 
pseudo cholinesterase. 
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The structure of OP compound is 
       O(s) 
 
    
                    R1                              P                               R2 
     
          
 
  X 
The central compound is phosphorous atom with a double bond to 
either oxygen (P=O) or sulfur (P=S) and three side chains, one x 
group,R1 and R2 may be alkyl, alkoxy, amido mercapten or other groups. 
The effectiveness as insecticides and the lack of persistence in the 
environment made the organophosphorous compound a great popularity.  
Due to their unstable structure these compounds disintegrate into 
harmless radicals within days of application. The OP compounds are used 
as insecticides in agriculture; some formulations are used in veterinary 
and human medicine. Some compounds are used as lubricants, 
plasticizers and flame retardens. Usage of some of these compounds as 
very potent agents of warfare is of global significance.   
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Anatomy and Physiology of Autonomic Nervous 
System. 
The autonomic nervous system  controls the visceral function of 
the body. Autonomic nervous system centers are located in the 
hypothalamus, brainstem and spinalcord. Anatomicaly this system is 
divided into sympathetic and parasympathetic system. Under sympathetic 
nervous system preganglionic fibers exits from spinalcord between first 
thoracic and second lumbar segments. A parasympathetic fiber leaves 
CNS through cranial nerves III, VII, IX, X and second to fourth sacral 
spinal nerves. Acetylcholine is a neurotransmitter found throughout the 
central nervous system, the sympathetic and Parasympathetic autonomic 
ganglia, postganglionic parasympathetic nervous system, most 
sympathetic glands and at the skeletal muscle motor endplate. 
Acetylcholine (Ach) is first synthesized by BAYER in 1867. The 
Ach is synthesized in the motor nerve terminal from choline and co-
enzyme A (CoA) by a process facilitated by the enzyme choline acetyl 
transferase. 
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Choline+Acetyl-CoA                                            Acetycholine   
         (Choline Acetyl Transferase) 
 
Acetylcholine: 20% of Ach is Present as free Ach in axoplasm and 
80% is contained within the vesicles. 
When a nerve impulse arrives at the nerve terminal causing release 
of acetylcholine into the synaptic space. Ach binds to and activates 
muscarinic and nicotinic receptors. Duration of Ach is curtailed as it is 
hydrolysed by the enzyme acetylcholinesterase. 
Acetyl choline                                  Acetate ion + choline 
                (AChE) 
The choline is reabsorbed actively into the neural terminal and 
reused in forming new acetylcholine. These events takes less than 5-10 
milliseconds and within about 20 seconds new vesicles will be formed 
and within another few seconds acetylcholine is transported into the 
interior of these vesicles and they are ready for a new cycle of 
acetylcholinesterase. The actions of acetylcholine in the body depend on 
the receptors involved and the site.  
Activation of the muscarinic receptors stimulates or inhibits 
cellular function through G protein at visceral smooth muscle, cardiac 
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muscle and secretory glands. Nicotinic receptors are Na channels at post 
synaptic membrane in autonomic ganglia and at skeletal muscle motor 
endplates. The enzyme acetyl cholinesterase (AchE) regulates the activity 
of acetylcholine within the synaptic cleft. There are two types of 
cholinesterase in human body. One is psedocholinesterase and other is 
true cholinesterase. 
True Cholinesterase- (RBC Cholinesterase)   
It is found in nervous tissue, erythrocytes, lung, spleen and 
greymatter. It is decreased in pernicious anemia and after antimalarial 
therapy. Ach is inactivated by combination with two sites on the enzyme 
RBC cholinesterase anionic site and esteratic site. 
Plasma cholinesterase (pseudocholinesterase) 
It is found in plasma, pancreas, liver and intestinal mucosa.  
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NEUROCHEMISTRY OF AUTONOMIC PATH 
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THE ORGAN SPECIFIC ARRANGEMENT OF ANS 
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Plasma cholinesterase deficiency could be due to physiological 
variation , disease, iatrogenic causes and genetic defects. 
1) Physiological variations:- 
a. Age:  
• A newborn has about 50% of normal PchE activity. 
• PchE activity reaches normal level at puberty. 
• In old age (75-80years) the activity is 75% of normal.      
b. During pregnancy PchE activity decreases 20 -30%.       
2. Diseases  
a.  Liver disease:  
• PchE activity decreases upto 50% in acute hepatitis, cirrhosis 
and liver metastasis. 
b. Renal disease:  
• PchE activity decreases to 30% normal in renal disease 
(uremia). 
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3. Drugs 
• Organophosphorous and organocarbamate compounds.   
• Anticancer drugs. 
• Ecothiopate eye drops. 
• Bombuteral . 
4. Genetic. 
Patients with atypical PchE have low PchE activity. 
Classification of Organophosphorous 
Compounds 
Organophosphorus Compounds are classified as 
 I. By chemical structure: 
      A) Alkyl phosphates: 
1. HETP (Hexaethyl tetra phosphate) 
2. TEPP (tetraethyl pyrophosphate) tetron,fosvex 
3. OMPA (octamethyl pyrophoramide) schardan 
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4. Dimefox (bis[dimethyl amino] flurophosphine oxide) 
5. Isopestox (bis[isopropylamino] flurophosphine oxide)pestox 
6. Malathion(5,[1,2dicarbethoxyethyl]0,o dimethyl dithiophosphate) 
7. Sulfoteppa(tetra ethyl 0,dithiopyrophosphate)-dithione Asp-47 
8. Systox,demeton(0,0 diethyl 10-2 ethylmercapto ethyl 
thionophosphate) 
9. Dipterex(0,0 dimethyl 2-2-2 trichloro hydroxyl ethyl phosphate-
tug orbait. 
B) Aryl phosphate  
1) Paroxon 
2) Parathion 
3) EPN-o, ethyl-o-p nitropheyyl benzene thionophosphate,EPN 
300 
4) Methylparathiono, o-dimethyl o-p nitrophenyl thiophosphate 
 
 
14 
 
II)  By Toxicity: 
Highly toxic(<D50<50 mg/kg) 
1. Azinophos-methyl 
2. Bomyl 
3. Carbophenthion 
4. Chlorfenvinphos 
5. Chlormephos 
6. Coumaphos 
7. Cyanofenphos 
8. Demeton  
9. Dialifor 
10. Dicrotophos  
11. Disulfoton  
12. EPN  
13. Famphur 
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14. Phenamiphos  
15. Fenophos phan  
16. Isophenfos 
17. Isofluorphate  
18. Mephosfolan 
19. Methmidophos  
20. Methidathion  
21. Mevinphos 
22. Monocrotophos  
23. Parathion-ethyl  
24. Parathion methyl  
25. Phovate 
26. Phostolan  
27. Phosphomidan 
28. Prothoate 
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29. Sulfotep 
30. Tetraethylpyrophosphate(TEPP) 
         
Moderate Toxicity (D50=50-1000mg/kg) 
1) Acephate 
2) Bensulide 
3) Chloropyrofos 
4) Crotoxyphos 
5) Cythioate 
6) DEF 
7) Deneton-s-methyl 
8) Diazinon 
9) Dichlorvos 
10) Dimethoate 
11) Edifenphos 
12) Ethion 
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13) Ethoprop 
14) Fenitrothion 
15) Fenthion 
16) IPB 
17) Leptophos 
18) Merphos 
19) Naled 
20) Phosalone 
21) Phosmet 
22) Pirimiphos-ethyl 
23) Profenofos 
24) Propetaamphos 
25) Pyrazophos 
26) Quinalphos 
27) Sulprofos 
28) Thiometon 
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29) Triazophos 
30) Tribufos 
31) Trichlorfon                                                                                                                                              
Low Toxicity(D50=>1000mg/kg) 
1) Bromophos 
2) Etrimfos 
3) Iodofenphos 
4) Malathion 
5) Phoxim 
6) Prophylthiopyrophosphate 
7) Temephos 
8) Tetrachlorrinphos. 
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PHARMACOKINETICS 
Most of the OP insecticides are rapidly absorbed by all routes 
dermal, respiratory, gastrointestinal and conjunctival. Plasma half life 
after single administration ranges from a few minutes to a few hours 
depending on the compound and the route of administration. Most of the 
op compounds are excreted almost entirely as hydrolysed products in the 
urine. 80-90% occurs within 48 hrs. A small proportion and their active 
forms are eliminated unchanged in the urine. Compounds like fenthion , 
fenithrotion are known to persist in the body for longer periods. 
Mechanism of Action 
OP compounds inhibit enzyme acetyl cholinesterase. The 
mechanism of inhibition of the enzyme is by reacting with the esteratic 
site on the acetyl cholinesterase molecule. The bond formed between 
phosphorus atom and the esteratic site of enzyme is stable and requires 
hours to weeks to reverse depending on the type of OP compounds. 
Phosphorylated enzyme is inhibited because of occupation of its active 
site. It is incapable of carrying out its normal function of hydrolyzing 
acetylcholine. The effect of the OP poisoning is therefore the result of 
continuing increased production of acetylcholine at the neuromuscular 
junction, resulting in depolorisation block. 
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This phosphorylated enzyme can undergo spontaneous hydrolysis 
or dealkylation. Due to spontaneous hydrolysis active enzyme 
cholinesterase is released and this is called reactivation. The 
phosphorylated enzyme can also undergo dealkylation. Once this occurs, 
reactivation is impossible. This process is called ageing1. Once ageing 
occurs recovery of cholinesterase activity depends on synthesis of new 
enzyme by liver which may take days or weeks. 
Hence the three independent reactions determine the speed of onset 
and severity of poisoning i.e 
1. Phosphorylation of cholinesterase by organophosphorus 
compounds. 
2. Reactivation. 
3. Ageing. 
Alkylphosphates (direct inhibitors) like malathion ,and 
arylphosphates(in direct inhibitors) like parathion. Poisoning by direct 
inhibitors of acetyl cholinesterase presents as an acute cholinergic crisis, 
they do not develop late type muscular weakness. Response to atropine is 
rapid. Indirect inhibitors do not develop signs of cholinergic crisis but 
show persistent fasciculations along with sudden increase in atropine 
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requirement. The incidence of development of late type of muscle 
weakness is high. 
In acute poisoning clinical manifestations  occur  after more than 
50% of serum cholinesterase is inhibited and severity of manifestations 
correlates with the degree of inhibition of serum cholinesterase activity. 
• Mild poisoning                - cholinesterase level reduces to 
20-50% 
• Moderate poisoning      - cholinesterase level 
reduces to 10-20% 
• Severe poisoning     - cholinesterase level reduces to 
lessthan10%. 
The correlation between the degree of enzyme inhibition and the 
severity of manifestations is pertinent only in the initial stage of acute 
poisoning ; inhibition is greater in repeated exposures2. Inhibition remains 
even after recovery from symptoms. 
CLINICAL MANIFESTATIONS16, 19, 20, 21, 24 
The clinical manifestations of OP poisoning depends on the agent, 
quantity and route of entry. Ingestion and inhalation result in more rapid 
development of symptoms than dermal exposure16. 
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After ingestion symptoms appear within 30-90 minutes and a 
maximum of 24 hrs in case of compounds which are highly lipophilic and 
which require metabolic bioactivation16. 
LOCAL EFFECTS: 
GI symptoms appear first before the onset of systemic symptoms. 
In inhalation typically exhibit respiratory effects. 
After ocular exposure symptoms generally begins in the eyes. 
Systemic effects:  Three well defined clinical phases are observed: 
1. Initial cholinergic phase. 
2. The intermediate syndrome (IMS) 
3. Delayed polyneuropathy. 
The cholinergic phase.18, 19, 20, 21, 22, 23, 24 
It is mainly due to accumulation of Ach at the cholinergic synapses 
and may be classified into 
1) Muscurinic(all postganglionic nerve endings) 
2) Nicotinic (Autonomic ganglia and skeletal muscle end plate) 
3)CNS manifestations(synapses in CNS ) 
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Each is summarized as follows. 
1) Muscuranic manifestation: 
Bronchial tree Tightness in chest, wheezing, 
dyspnoea, increased bronchial 
secretions,cough,pulmonary edema, 
cyanosis.  
Gastro intestinal system Nausea, vomiting, abdominal 
tightness, cramps, diarrhea, tenesmus, 
fecal incontinence. 
Sweat glands Increased sweating 
Salivary glands Increased salivation 
Lacrimal glands Increased secretions 
Cardiovascular system Bradycardia, hypotension. 
Pupils Miosis 
Ciliary body Blurring of vision 
Bladder Frequency,urinary incontinence. 
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2)Nicotinic manifestations: 
Striated muscle Muscle twitching, cramps, 
fasciculation,respiratory muscle 
weakness. 
Sympathetic ganglia Pallor, tachycardia,hypertension. 
 
3) Central nervous system manifestations: 
Anxiety,restlessness, giddiness, emotional liability,slurred speech, 
ataxia,seizure, drowsiness,confusion,difficulty in concentration, 
headache. nightmare, insomnia, excessive dreaming, apathy,tremor, 
depression,generalized weakness,coma,absence of reflexes,cheyne-stokes 
respiration,depression of respiratory and circulatory centres with 
Dyspnea,Hypotension,Cyanosis. 
1.The combination of symptoms may vary13, 14, 18, 19, 21, 22, 23 
The predominant clinical finding are usually muscuranic which is 
followed by CNS and then nicotinic manifestations GI symptoms are first 
to appear after ingestion. 
2. The intermediate syndrome (IMS)12, 24 
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        After apparent recovery from cholinergic crisis muscle 
paralysis occurs, but before the expected onset of the delayed 
polyneuropathy has been identified as “Intermediate syndrome(IMS)”. 
This is type 11 paralysis first described by Wadia et al. In 1974 and later 
christened as “Intermediate syndrome(IMS)” by Senanayake,Karalliedde 
L. The syndrome is of Acute onset, seen within 24-96 hrs(1-4days) after 
poisoing,affecting conscious patients without fasciculations or other 
cholinergic manifestations. 
The cardinal features of this syndrome is muscle weakness 
affecting predominantly proximal limb muscles and neck flexors.The 
muscles innervated by motor cranial nerves III,VII and X are affected in 
different combinations. These patients were conscious and showed 
marked anxiety,sweating and restlessness caused by progressive hypoxia. 
These patients try to situp in bed,having bathed in sweat, with accessory 
muscles of respiration in action. The neck muscle weakness was a 
constant feature. Patients were unable to raise head above the pillows. 
Weakness of shoulder abduction and hip flexion was also noted. 
However normal strength in the distal muscle gives a false 
impression that the limbs are spared. Tendon reflexes are diminished or in 
most patients. There is no sensory impairment. 
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Complete recovery occurs within 4-18 days if adequate ventilator 
support is given. But altered function at neuromuscular junction may 
persist upto 2 yrs after its occurrence. 
The syndrome carries great mortality if not recognized in time and 
treated. The agents commonly responsible are fenthion, monochrotophos 
and Dimethoate. Respiratory insufficiency develops over 6 hrs 
approximately. Initially patient uses accessory muscles of ventilation. 
There is increase in ventilator rate, sweating, restlessness and later 
cyanosis if not recognized patient soon becomes unconscious and death 
follows. A consensus from literature search appears that IMS may result 
from inadequate therapy with oximes. 
   IMS is likely to result from post synaptic neuromuscular 
dysfunction. 
The symptom complex begins at a time when the cholinesterase 
function is very low and the OP compounds is still detectable in the body. 
As blood levels of OPC’s fall and OPC’s tissue redistribution 
occurs the motor end plates may be rechallenged by the cholinesterase 
inhibitor in the presence of inadequate circulatory oximes. 
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3. Delayed polyneuropathy.13, 19, 21 
Though uncommon in India the neuropathy develops following a 
latent period of 2-4 weeks after the cholinergic crisis. The main clinical 
features are weaknessof distal muscles of feet and hand. The weakness is 
preceded by pain and parasthesia of limbs. Wasting of distal muscles of 
particularly small muscle of the hand and those of anterior and peroneal 
compartments of the leg is a inevitable consequence. In some patients 
pyramidal tract signs appear after a few weeks or few months. Recovery 
is variable. 
The phosphorylation of an enzyme neuropathy target esterase in 
nervous tissue is considered to be responsible for the polyneuropathy. 
Several out breaks of OP induced delayed polyneuropathy have occurred 
in various countries where the poison was traced in most instances to be 
accidental contamination or adultration of cooking oils with mineral oils. 
In 1930’s more than 50000 US citizens became paralysed after drinking 
Jamica ginger contaminated with TOCP. 
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OTHER EFFECTS OF OP POISOING: 
Cardiovascular system32,33,34,35 
Tachycardia and increased blood pressure occurs in initial  stage 
and Bradycardia and low blood pressure in the later stage. Commonest 
effect observed was tachycardia. Late onset bradycardia is attributed to 
direct action on myocardium by organophosphorus compound. 
Hypertension occurs due to the combined effect of vasoconstriction from 
cholinergic stimulation of sympathetic ganglia and noradrenaline release 
from adrenal medulla. Hypotension may also occur due to muscarinic 
action or blocking of ganglia by hyperpolarisation. Cardiac 
manifestations including atrial fibrillation, conduction block and 
ventricular fibrillation and further usually occur in terminal stages. 
The cardiovascular actions of anticholinesterase are extremely 
complex, as they reflect at any moment the algebraic sum of the 
excitatory and inhibitory actions of the accumulated endogenous acetyl 
choline at several levels of the innervations of the heart and blood 
vessels. ECG changes seen were sinus bradicardia, right axis 
deviation,AV Block, ST segment depression in all leads and T wave 
inversion. A combination of metabolic and electrolyte derangements 
cause myocardial injury, autonomic dysfunction and asyncronus 
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repolarisation producing variable QRS morphology and varying RR 
interval. 
Sinus tachycardia could be due to effect of cholinesterase 
inhibition, acting either directly on the myocardium and conducting 
tissues or through neurogenic mechanisms. Right axis deviation could be 
related to pulmonary oedema. ST segment and T wave inversion has been 
suggested to be due to potassium shift or disturbance of other ions 
transport across membrane. 
2. Respiratory system37, 38 
Respiratory arrest a common terminal manifestation of OP 
poisoning is produced by over stimulation of 3 types of receptors. It can 
be recalled that muscarinic action produces increased bronchial 
secretions, Bronchoconstiction leading to pulmonary oedema and chest 
tightness. On other hand nicotinic action produce intercostals muscle 
paralysis and respiratory muscle weakness leading to respiratory 
paralysis. 
Direct action on respiratory center reduces respiratory rate. 
Combined effects of all these factors results in respiratory failure. 
During clinical course it was observed by M.L.Chhabra et al,    
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That some cases apparently recover in respect of level of 
consciousness and pulmonary oedema, to fall back into a second and 
often a terminal phase of acute pulmonary oedema . Inspite of the fact 
that atropine is continued in optimum doses. Limaye et al suggested that 
diazinon exerts a toxic action on myocardium leading to toxic 
myocarditis and explained this as the genesis of the rebound or second 
phase of pulmonary oedema . 
3. Altered immunity to infection: 
The immunosuppression is associated with severe cholinergic 
stimulation either from a direct action of acetylcholine on the immune 
system or secondary to toxic chemical stress associated with cholinergic 
poisoning. 
4.Gastrointestinal system 
After ingestion of organophosphate compounds the initial 
symptoms may be increased salivation, nausea, vomiting, abdominal 
tightness and cramps are the commonest. Other muscarinic manifestation 
include diarrhea, tenesmus and faecal incontinence. 
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5. Effects on reproduction: 
Following organophosphorus   poisoning in females abortions were 
being reported. 
6.Effects on temperature regulation: 
It has been noted in several case studies with incidence of 7% of 
derangement of temperature regulation in the form of hypothermia. Some 
may experience fever lasting for many days a biphasic response. 
7. Vocal card paralysis : 
In few patients vocal card paralysis was reported within 2 days. 
8. Effects on other systems: 
Eyes: myopia and pigmentary degeneration of retina. 
Joints:arthritis, cerebellar ataxia. 
Interference with mitochondrial oxidative metabolism. 
9. Changes in metabolism and endocrine activity : 
Transient hyperglycaemia and glycosuria are often found in severe 
OP poisoning. Absence of acetone bodies differentiates from diabetic 
coma, except for coma in diabetic patient due to hyperosmolarity from 
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excessive blood glucose. Changes in diurnal pattern of plasma 
adrenocorticotrophic hormone have been reported. Nicotinic receptors 
also function in brain pathways that increase the release of several 
pituitary hormones,including vasopressin, adrenocorticotrophic hormone 
and prolactin. Significant decreases in serum concentration of thyroxin 
and tri-iodothyroxine and an increased secretion of thyroid stimulating 
hormone were observed after OP poisoning. Hyper amylasaemia and 
acute pancreatitis have been reported. 
Grading of severity of organophosphorus poisoning: 
There are several system of grading of severity in acute 
organophosphorus poisoning. Recently Senanayake N.(1993) proposed 
Paradeniaya  Organophosphorus Poisoning  (POP) scale for grading the 
severity,which is based on five cardinal manifestations of 
organophosphorus poisoning as given below in the table 
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S.NO PARAMETER SCORE 
1. Miosis 
- Pupil size >2mm 
-Pupil size ≤2mm 
 -Pupils pin point 
 
0 
1 
2 
2. Fasciculations 
-None 
-Present but not generalized or continous 
-Generalized and continous with central 
cyanosis 
 
0 
1 
 
2 
3. Respiration 
-Respiratory rate ≤20/min 
-Respiratory rate >20/min 
-Respiratory rate >20/min with central 
cyanosis 
 
0 
1 
2 
4. Bradycardia 
-Pulse rate >60/min 
-Pulse rate 41-60/min 
-Pulse rate < 40/min 
0 
1 
2 
5. Level of consciousness 
-Conscious and rational 
-Impaired, responds to verbal commands 
-Impaired, no responds to verbal 
commands(if convulsion present add 1) 
0 
1 
2 
 TOTAL 11 
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POP scale uses only cardinal clinical manifestations where each 
sign is given a score according to the severity and all are added up to 
assess the severity on a 1-11 scale. 
Peradeniya organophosphorus poisoning (POP) scale grading. 
  Score                                                                 Grade 
  <4                                                                      Mild 
  4-7                                                                     Moderate 
   >7                                                                      Severe. 
The revised grading for  organophosphorus poisoning by Bardin et 
al (1990) to assess the severity was proposed. This grading includes the 
history of intake exposure to  organophosphorus, attempted suicide, 
clinical signs and makes use of investigations(decreased PaO2 and 
abnormal chest roentgenogram) in early assessment of respiratory failure. 
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Revised grading for organophosphorus poisoning : 
  Grade                       Criteria 
 Mild poisoning       History of intake/exposure 
                                       Mild signs: 
Normal consciousness 
Secretions 1+  
 Fasciculations 1+ 
Severe poisoning           Severe signs: 
Altered consciousness 
Secretions 3+ 
Fasciculations 3+ 
Life threatening poisoning        Suicide attempt 
                                                               Stupor 
                                                               PaO2<75mm Hg(<10mm Hg) 
                                                               Abnormal chest roentgenogram.   
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DIAGNOSIS 
1. History or evidence of exposure to organophosphate. 
2. Signs and symptoms of poisonoing. 
3. Improvement of these signs and symptoms after the 
administration of Pralidoxime and atropine. 
4. Inhibition of cholinesterase activity of blood. 
In most patients a history of exposure to organophosphate 
insecticide can be obtained. After suicidal attempt a container is often 
found. Most organophosphates used as insecticides have characteristic 
garlic like odour and patients who have ingested or absorbed these 
compounds usually retain such an odour for several days. The 
organophosphate compound can frequently be identified in gastric 
aspirate, skin, urine, or clothing by means of gas or thin layer 
chromatograph, or by demonstration of anticholinesterase activity in 
vitro. Metabolites of organophosphate may also be detected in gastric 
aspirate, blood or urine. P-nitrophenol is a metabolite of parathion, 
methyl-parathion chlorothion, dicapthon and EPN, and its detection in 
urine indicates prior exposure to one of these or related compounds. 
However a history of exposure and detection of organophosphate or its 
37 
 
metabolites does not always indicate that signs and symptoms are due to 
organophosphate poisoning since the patients may have other diseases. 
Signs and symptoms do not occur unless the amount of absorbed 
organophosphate is so great acetylcholinesterase of synapses is inhibited 
over the critical level. 
 For example tests for urinary p-nitrophenol were positive in 75 out 
90(83%) farm workers after spraying parathion in the field in one study 
and yet they did not have any symptoms and p-nitrophenol bore no 
relationship to the degree of inhibition of concentration of serum 
cholinesterase activity.2 
The signs of organophosphate poisoning that are most helpful 
diagnosis are miosis and muscular fasciculations which are almost always 
present in moderately severe or severe poisoning 
Other signs that are helpful in diagnosis include excessive 
sweating, salivation, lacrimation and bronchial secretions. The occurrence 
of frothy sputum and basal pulmonary rales may lead to an erroneous 
diagnosis of pulmonary oedema. Careful observation of the effect of 
pralidoxime and atropine is valuable for differential diagnosis. 
Intravenous injection of 1 gm pralidoxime generally causes some 
recovery from signs and symptoms particularly in parathion poisoning. 
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Patient with organophosphate poisoning are resistant to the action of 
atropine and therefore failure of 1 to 2mg of atropine administered 
parenterally to produce signs of atropinization (flushing, mydriasis, 
tachycardia or dryness of the mouth and nose) indicates  organophosphate 
poisoning whereas occurrence of these signs casts doubt in the diagnosis 
or indicated that poisoning is of mild degree.2 
Inhibition of cholinesterase activity of the blood is the most 
specific test for systemic absorption of an organophosphate 
anticholinesterase compound. Normal cholinesterase activity of the blood 
excludes systems poisoning by these compounds. Most of the 
organophosphate used as insecticides inhibit both psedocholinesterase 
and acetylcholinesterase. Estimation of erythrocyte cholinesterase 
(acetylcholinesterase) is theoretically preferred since it would reflect the 
degree of inhibition of synaptic cholinesterase . Estimation of plasma 
cholinesterase (psedo cholinesterase) has an advantage because the 
measurement is simpler and more accurate than estimation of erythrocyte 
cholinesterase following pralidoxime administration.  
 Erythrocyte cholinesterase indicates the effectiveness of 
pralidoxime and   plasma cholinesterase indicates the prior presence of 
cholinesterase inhibition even after recovery of erythrocyte cholinesterase 
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activity by pralidoxime. In acute poisoning manifestation generally occur 
only after more than 50% of  plasma cholinesterase is inhibited and the 
severity of manifestations parallel the degree of inhibition of serum 
cholinesterase activity 20 to 50 % of normal in mild poisoning, 10 to 20% 
of normal in moderately severe poisoning and less than 10 % in severe 
poisoning. The correlation between the degree of plasma cholinesterase 
inhibition and the severity of manifestations is pertinent only in the initial 
stage of acute poisoning and inhibition is greater in repeated exposures, 
inhibition remains even after recovery from symptoms.2 
In severe poisoning return to normal level requires about 3-4 weeks 
for plasma cholinesterase and about 5 weeks or more for erythrocyte 
cholinesterase when pralidoxime is not administered. 
Therefore plasma cholinesterase seems to recover far more rapidly 
than RBC cholinesterase. 
 Blood/serum chemistry : 
 Serum electrolytes, Random blood glucose, Serum 
creatinine  
 Hematology (including white cells count as leukocytosis 
is common) 
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 Plasma cholinesterase 
Sequential rise of plasma cholinesterase activity every few days for 
14 to 28 days may confirmation of organophosphate exposure in 
the absence of pre exposure baseline values.3 
 Serum amylase 
 Lipase 
 Serum levels of organophosphorus compounds and their 
metabolites. 
 Aretrial Blood Gas : 
 Aretrial blood gas analysis in patients with CNS or 
respiratory depression. 
 Urine analysis : 
 Estimation of excretory products of organophosphorus 
agents. 
 Chest radiograph : 
 Electrophysiological studies : 
 Electromyography 
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 Train of four 
 Single fibre electromyography 
 Indirect laryngoscopy : 
 To evaluate vocal cord functions 
 Ultra sound/CT scan : 
 To evaluate pancreatic status 
 Positron emission tomography : 
 To estimate cortical visual loss following respiratory 
failure. 
 
MANAGEMENT: 
I. ACUTE CHOLINERGIC CRISIS 30 
All patients should be managed as emergencies in hospital. 
A. First aid 
B. Prevent further absorption of insecticide 
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C. Specific antidote therapy 
1. Anticholinergic medication 
2. Reactivation of Aectylcholine-oximes 
D. Benzodiazepines 
E. Other medications 
Mild poisoning:  warrants admission to hospital for atleast 72 hrs for 
observation and treatment. 
Mooderate poisoning:  admission in ICU. 
Severe poisoning:  merit immediate transfer and admission to ICU. 
 
A. First Aid: 
     a)  Remove patient from the contaminated environment. 
     b)  Remove  contaminated clothing. 
     c) Wash skin with soap and water and eyes with water. 
     d)  Assess breathing and circulation. 
     e)  Resusciate if necessary 
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     f) Support vital function if necessary 
 O2 inhalation 
 Lung ventilation 
 Ionotropes 
    g) Control of convulsion 
    h) Monitor ECG, blood pressure, O2 saturation,ventilation,level  
        of consciousness. 
B. Prevent further absorption of insecticide: 
a) Gastric lavage: performed using largest possible oro-gastric tubes 
with 50-100ml of fluid/lavage,preferably within 1 hr of ingestion 
protect airway in patients with impaired consciousness. 
b) Administer activated charcoal: dose initial 60-100 gms, followed 
by 0.25 gms to 0.5gms/kg every 1-4 hrs. 
C. Specific antidotal therapy: 
Treatment aims: 
     a) Reversal of synaptic biochemical abnormalities. 
      b) Reversal of cholinesterase blockade. 
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This is activated by administering sufficient quantity of two 
complimentary medications. 
   i)  Anticholinergic medication- atropine or glycopyrrolate. 
    ii)  Reactivation of AchE-oximes. 
i)   Anticholinergic medication: 
 Atropine:11, 32, 33 
 It is a tertiary amine, a competitive antagonist of acetylcholine at 
muscuranic post synaptic membrane and in the CNS. In symptomatic 
poisoned adults, atropine is given as 1-2mg IV or IM(0.02-0.05mg/kg in 
children). 
If there is no effect within 10 minutes, the dose is doubled every 5 
to 10 minutes until  muscarinic symptoms are relieved.20 
The action of 2 mg atropine sulphate begins 1 to 8 minutes after 
IV,IM administration respectively and it is maximal at 6-15 min.26 
Half life elimination 2-5 hrs. 
 Alternatively atropine can also be given by continuous infusion 
Atropine 30 mg in 200ml of NS at the rate of 0.02-0.08mg/kg/hr titrate 
against the important parameters for adequate atropinization 
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supplemented by  giving additional IV boluses of atropine 1-5mg to 
regain quick control of secretions or severe bradycardia when indicated.30 
Once signs of adequate atropinization occurs the dose should be 
adjusted to maintain this effect for at least 24-48hrs, carefully withdrawn 
once the patient is adequately stabilized, observed for 72 hrs following 
termination of atropine before discharge from the hospital.30 
Atropine should be restricted at first sign of recurrences of 
cholinergic symptoms. 
The patient should be oxygenated prior to atropine administration 
in order to prevent ventricular dysarrhymias associated with hypoxia. 
The end point of Anticholinergic treatment is clearing of secretions 
from tracheobronchial tree and drying of most secretions. 
Pupillary dilatation is an early response to atropine, but it is not 
therapeutic end point. 
Tachycardia is not a contraindication to atropine. 
Diaphragmatic muscle weakness is important contributor to 
hypoventilation and it is not reversible with atropine. 
Side effect –atropine crosses the blood brain barrier and may cause 
46 
 
severe toxic effects such as confusion, psychosis, coma, seizure, delirium, 
hallucinations, fever, tachycardia and ileus. 
Monitor with continuous pulse oxymetry, cardiac monitoring 
during atropine administration-to observe cardiac dysarrhythmias early 
and late. 
The studies concluded that patient who receive aggressive heavy 
dose of atropine, survived more frequently than those who received 
inadequate doses or none at all. 
Also studies observed that continuous high dose atropine infusion 
is more effective than intermittent bolus doses. 
 
Glycopyrrolate: 33 
 It is quaternary ammonium compound may be substituted for 
atropine in patients with a clear sensorium with no evidence of central 
toxicity. 
 It has many advantages over atropine they are  
 Better control of secretions. 
 Lesser tachycardia. 
47 
 
 Fewer CNS side effects, because unlike atropine 
glycopyrrolate does not cross the blood brain barrier.   
Fewer respiratory infections-this may be consequence of better 
control of endobronchial secretions,decreased mucous impaction in the 
smaller airways, followed by decreased obstruction and infection. 
Dose 0.05mg/kg or given at increments of 0.25mg repeated every 
5-10 minutes until Anticholinergic over activity is reversed or upto 
maximum of 2.5mg/day. 
ii) Reactivation of AchE-oximes 
 Derivatives of hydroxamic acid and a number of other oximes were 
shown to reactivate cholinesterase inhibited by organophosphorus 
compounds. 
Mode of action: 
1. Functions by nucleophilic and detoxification attack on the 
phosphorylated enzyme, removing the bulky phosphate moiety and 
completely restoring normal acetylcholinesterase activity. 
2. Direct reaction and detoxification and unbound the OP molecules. 
3. Endogenous anticholinergic effect in normal doses. 
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Dose: 
• 1 gm every 8-12 hrs IV in adults 
• 25-50 mg/kg in children 
Therapeutic response observes is  
• Recovery of consciousness 
• Disappearance of manifestation, especially, weakness and 
fasciculations occurs within 10-40 minutes. 
The second and third doses may be administered at interval of 1 hr 
if indicated by the persistence of muscle weakness.30 
Disadvantages: 
In view of the short elimination half life of 1-2 hr following IV 
bolus (intermitent) injection (1 gm 8 hrly) it would maintain the desired 
target  concentration for <5 hrs in 24 hr period. 
Therefore recommended regimen is  
• Loading dose of20-50mg/kg based on symptoms severity(dissolved 
in 0.9%NS infused over 30 minutes) 
• Followed by a continuous infusion of 10-20mg/kg/hr.13 
• The maximum recommended dose in adults is 12gm in 24 hours.13 
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PAM should be administered soon after diagnosis is made. Once 
the phosphorylated enzyme has aged the phosphate group becomes 
irreversibly bound to the enzyme and oxime therapy is no longer 
effective. Probably more effective if given within 6 hrs of poisoning. 
Maintenance and duration of treatment: 
 Average duration of treatment 5 to 7 days. The therapeutic 
concentration of the oximes should be maintained to regenerate as much 
active enzyme activity as possible until the OP compound has been 
eliminated. 
OP residues that are present may bind the circulatory free PAM 
and lower its serum concentration. Therefore PAM should be continued 
as long as nicotinic symptomspersist those who develop the IMS are 
given the drug for longer periods until they are weaned from ventilator 
care. 
Delayed clinical manifestations occur with fat soluble 
organophosphates like fenthion, chlorfenthion and parathion. 
Cardiac and respiratory arrest have known to occur. Cardiac 
monitoring and blood pressure monitoring are adviced during and for 
several hours after the infusion of oximes. 
50 
 
Rapid infusion can cause tachycardia, laryngospasm,muscle 
rigidity and weakness. 
Drug interactions: 
Drugs which should be avoided when PAM is given are 
Morphine,aminophylline,succinylcholine.theophylline,resrpine and 
phenothiazines like tranquillizers. 
The other commonly used oxime is obidoxime 
Is effective in smaller doses i.e. 250mg IV/IM as a slow bolus or 
infusion. 
Is more potent cholinesterase reactivating agent than pralidoxime 
but its toxicity is slightly greater. 
The drug combination of pralidoxime and atropine is 
complementary and superior to used alone. 
D. Benzodiazepins:13 
They are used when the patients are agitated and who develop 
seizures. 
Diazepam appears to counteract some aspects of CNS derived 
symptoms which are not affected by atropine.13 
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E. Other medications: 
 a. Magnesium; 
          It was thought to be counteracting the direct toxi inhibitory 
effect of OPC’c on N.K.Atase.Singh et al administered magnesium 
sulphate 4mg IV to patients intoxicated with OP and observed that the 
neuroeletrophysiological effects that had been observed earlier were 
reversed. 
b.Clonidine: 
• Protective effects of clonidine or likely to involve multiple 
effects including 
• Blockade of acetylcholine release and post synaptic 
muscarinic receptors. 
• Transient inhibition of  acetylcholinesterase 
• Inhibits the release of acetylcholine from central and 
peripheral cholinergic neurons.13 
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MANAGEMENT OF INTEDRMEDIATE SYNDROME:14 
PAM should be continued and provide adequate ventilator support. 
Patient should be kept in hospital upto 5 days because patient may 
develop respiratory difficulty during the recovery phase of cholinergic 
crisis. 
During the intermediate syndrome patient may develop profuse 
diarrhea. They should be managed with fluids and electrolytes. 
MANAGEMENT OF DELAYED POLYNEUROPATHY: 
There is no specific drugs.  
Physiotherapy and regular exercise may improve the muscle 
weakness. 
MORTALITY:   
Mortality rate in India and other developing countries ranges from 
4-38%. 
Mortality depends upon the poison used, quantity ,duration after 
exposure and atropinisation of all the toxins.  
Malathion has the lowest toxicity because of rapid hydrolization of 
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carboxy ester group to    products with little or no anticholinesterase 
activity. Fenthion has the maximum mortality. 
 Early death is due to 
 1)  CNS depression 
 2)  Seizures 
 3)  Ventricular arrhythmias 
 4)  Respiratory failure due to 
 Excessive bronchial secretions 
 Bronchospasms 
 Pulmonary oedema 
 Paralysis of respiratory muscles 
 Apnea due to depression of medullary respiratory center. 
Late death is due to 
        1.   Respiratory failure associated with 
                  Infection  
                   Pneumonia 
                  Septicaemia 
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         2. Complication due to mechanical ventilation 
     3. Ventricular arrythymias ,sudden collapse. 
PATHOPHYSIOLOGY OF SERUM CREATINE 
PHOSPHOKINASE     
   Experimental study done in rats with soman an OP showed 
decrease in tissues ChE activity accompanied by increase in serum CPK 
activity. The CPK activity was significantly elevated in poisoning cases 
and more significant changes in the patients who died due to poisoning.  
       Significant increase in serum creatine phosphokinase coincides 
with the appearance of myonecrosis , destruction of muscle membrane. 
 Subjunctional changes in the muscle fibers, such as 
supercontraction of subjunctional sarcomeres as well as disruption of 
cytiarchitectural organaizations, are always present. The initial changes 
are in the mitochondria, which swell  and then show lysis of the central 
cristae.  
 Myelin figures beneath the end plate are frequently observed , here 
as the region more distal to the end plate is less affected .the nucleoli of 
the muscle cell nuclei are enlarged and move to the periphery of the 
nucleus. This Myopathy can be induced with several OP or CM AChE 
inhibitors, such as paraoxon, diisopropylphosphofluoridate (DPP), 
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pyridostigmine, aldicarb and carbofuran and the OP nerve agents soman, 
sarin, tabun and VX.Despite the diversity in structures of these AChEIs, 
the induced myopathic changes are the same, suggesting a common 
mechanism. This mechanism is an excess of Ach and its prolonged 
interactions with nAChRs and not a direct action of these inhibitors on 
the muscle. The common denominator is muscle hyperactivity, such as 
fasciculations. 
     Carbofuran in concentrations that cause fasciculations and 
Myopathy produced a significant and maximal increase in serum total CK 
activity that was seen as early as 0.5hrs after carbofuran injection and 
remained elevated for 3hrs. Under the influence of acute carbofuran 
intoxication, examination of thr serum and diaphragm revealed several 
characteristic changesin CK isoenzymes. The activity of the CK-MM 
isoenzyme was elevated more than two fold in the diaphragm within 
0.5hr and remained significantly higher than control at 24hr. Such an 
increase in CK-MM activity was also seen in the serum at the time when 
fasciculations were evident(1-3hr), indicating damage to the muscle fiber 
integrity. The increased leakage of CK subsided following restoration of 
normal muscle activity.  
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Normal CPK in Male – 51-294 I.06U/L 
Female – 39-238 IU/L 
POP Score Serum CPK  
Mild 0-3 273.53 
Moderate 4-7 456 
Severe 8-11 1032.57 
 Ref: Toxicology of Organophosphate & Carbamate Compounds. 
Author Ramesh Gupta 
 Toxicology International Jul-Dec-2011/vol-18/ issue-2. 
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MATERIALS AND METHODS 
 This study was conducted at Government Mohan Kumaramangalam 
Medical College Hospital over the period of two and half years from June 
2010 to December 2012.  
 50 patients who fulfilled the  criterias were chosen as study subjects. 
  Study design: 
Prospective and observational study. 
Inclusion criteria: 
Patient exposure to OPC poison within six hours, without any prior 
treatment. 
 Exclusion criteria: 
Patients with history of illness like Myopathy,chronic renal 
disease,epilepsy, myocardial infarction, sepsis and trauma.   
Patients on medication like statins,,fibrates,aspirin,anticoagulants, 
dexamethasone. 
  Patients receiving intramuscular injections. 
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Method of collection of data: 
After obtaining the informed consent details of history and clinical 
examination were recorded. 
Peradeniya OP poisoning scale was applied to all study subjects 
and the severity of OP poisoning was graded as mild, moderate, 
severe. 
In all study subjects blood was collected on admission for 
estimation of serum creatine        phosphokinase. 
Other routine investigations were done. 
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RESULTS 
 The following observations were made after studying 50 cases of 
suspected      OPC poisoning. 
TABLE – 1: Age Distribution 
Age group (in years) Total Percentage (%) 
<20 7 14 
21-30 18 36 
31-40 12 24 
41-50 5 10 
51-60 5 10 
>61 3 6 
TOTAL 50 100 
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Figure 1 Graph showing age 
distribution
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Age group ranged from 17 years – 66 years. Majority of the patients were 
in the age group of 21-30 years which comprised 36% of the study 
patients. 
61 
 
TABLE – 2 Sex wise Distribution 
Gender No. of  cases Percentage(%) 
Male 33 66 
Female 17 34 
 
Figure 2: Graph showing sex distribution 
 
In this study 66% of patients were male and 34% were females. Males 
were more than females 
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TABLE - 3 Showing Marital status 
Marital status No. of patients Percentage 
Married 37 74 
Unmarried 13 26 
TOTAL 50 100 
 
Figure 3: Graph showing Martial status 
 
In our study 74% of patients were married, 26% patients were unmarried. 
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TABLE - 4 Occupation of patients 
Occupation No. of patients Percentage 
Agriculture 7 14 
Coolie 16 32 
House wife and 
unemployed 
12 24 
Private 5 10 
Student 10 20 
TOTAL 50 100 
 
Figure 4: Occupation of patients in % 
 
32% in our study were coolies. Next major group was constituted by 
housewives. 
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TABLE-5 Showing type of poison 
Type of poison No of cases Percentage 
Chloropyrofos 5 10 
Dimethoate 4 8 
Endosulphan 3 6 
Malathion 2 4 
Monocrotophos 20 40 
Phenthiole 50% with epichlorhydrin 7 14 
Tic 20 3 6 
Triazophos 6 12 
TOTAL 50 100 
 
Figure 5: Type of 
poison
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Most common poison encountered is Monocrotophos followed by 
Phenthiole 50% with epichlorhydrin.  
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TABLE 6: Showing quantity of poison consumed: 
Amount of poison 
consumed in ml 
No of patients Percentage 
<30 19 38 
31-50 13 26 
51-75 9 18 
>75 9 18 
 
Figure 6: Graph showing the amount of poison consumed 
 
38% of the patient has consumed <30 ml.  
18% of the patient has consumed >75 ml.                                                                                                                                     
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TABLE – 7 Clinical Signs 
Sign No. of cases Percentage (%) 
Miosis 44 88 
Fasciculation 31 62 
Respiratory rate >20 38 76 
Heart rate 17 34 
Altered consciousness 19 38 
Seizures 2 4 
 
Figure 7 Graph showing Clinical Signs 
 
In this study most common clinical sign is Miosis followed by 
Tachypnoea  
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TABLE-8 Showing severity according to Peradeniya  
OP poisoning scale 
Severity No of patients Percentage 
Mild 26 52 
Moderate 20 40 
Severe 4 8 
TOTAL 50 100 
Figure 8: Graph showing severity of poisoning to POP scale 
 
 
More than 50% of patients in our study belong to mild grade of poisoning 
with a POP score1-3. 
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TABLE-9. SERUM CPK LEVEL 
CPK Range IU/L No of patients Percentage 
<350 25 50 
351-500 9 18 
501-750 4 8 
751-1000 11 22 
>1000 1 2 
   
Figure 9: Graph showing Serum CPK Level 
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TABLE-10 Showing correlation between serum CPK level and POP 
score 
CPK range POP score No of patient Percentage 
<350 0-3 25 50 
351-500 4-5 9 18 
501-750 6 4 8 
751-1000 7-8 11 22 
>1001 8 1 2 
 
 
Serum CPK Level was directly related to the severity of the Peradeniya 
OP Poisoning Scale. (Pearson correlation P =0.000) 
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TABLE-11 Showing correlation between serum CPK level and 
ventilatory support 
Serum CPK IU/L Ventilatory  Support Total 
 YES NO  
<350 0 25 25 
351-500 3 6 9 
501-750 4 0 4 
751-1000 10 1 11 
>1001 1 0 1 
 
Figure 11: Graph showing correlation between serum CPK level and 
ventilator support 
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TABLE - 12 showing correlation between POP scale and ventilatory 
support 
POP scale         Ventilatory   support TOTAL 
 YES NO  
Mild 0 26 26 
Moderate 14 6 20 
Severe 4 0 4 
TOTAL 18 32 50 
 
 
Figure: 12 showing correlation between POP scale and ventilatory 
support
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TABLE 13 Outcome of the patients 
Outcome No of patients Percentage 
Survived 40 80 
Expired 10 20 
TOTAL 50 100 
 
Figure 13: Graph showing outcome of patients. 
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DISCUSSION 
 Organophosphorus compound poisoning is a major public health 
problem in the developing world. Since a high proportion of Indian 
population is involved in agriculture, the incidence of suicidal OPC 
poisoning is increasing as a result of easy access to highly toxic pesticide 
in the situation of stress. 
 The present study was conducted in Govt Mohan Kumaramagalam 
Medical college from June 2010 to December 2012. The clinical and 
diagnostic findings of this study is compared with studies in literature.                           
 Age of the patient:  
In our study majority of the patients were in the age group of 21-30 
yrs. (36%). 
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COMPARING THE AGE GROUP WITH MAXIMUM 
INCIDENCE          
Age group Present 
Study(%) 
P.S.Shankaretal(%) Goeletal(%) Saadehetal(%) 
<20 14 25 - 46 
21-30 36 59.4 86.4 - 
31-40 24 9.4 - - 
41-50 10 6.2 - - 
51-60 10 - - - 
>61 6 - - - 
 
 In this study maximum incidence of poisoning was among less 
than 30yrs of age, which was comparable to studies done by P.S.Shankar 
et al and Goel et al. 
SHOWING SEX RATIO 
Age 
group 
Present 
study 
P.S. 
Shankar et 
al 
Goel et 
al 
Thomas et 
al 
Shoba 
TR et al 
Male 66 71.85 72 56 56.5 
Female 34 28.15 28 44 33.4 
M:F - 2.5:1 1.27:1 1.27:1 1.3:1 
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 In this study incidence was more common in males with M: F of 
1.9:1. This is consistent with studies of Goel et al,Thomas et al,Shoba et 
al reports. 
COMPARING COMMONLY ENCOUNTERED OP COMPOUNDS. 
OPC Present study(%) Goel et al Avasthi et al 
Chlorpryphos 10 - - 
Dimethoate 8 8.74 24.1 
Endosulphan 6 - - 
Monocrotophos 40 26.21 41.3 
Phenthiole 14 - - 
Malathion 4 15.3 - 
Tic 20 6 - - 
Triazophos 12 - - 
 
 Monocrotophos was the commonest used OPC in this study which 
was comparable to Avasthi et al studies.  
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COMPARISON OF CLINICAL SIGNS 
Signs 
Present 
study 
Reihman      
et al 
Goel et al 
APN 
Kumar 
Miosis 88% 60% 95% 62% 
Fasciculation 62% 8% 55% 38.6 
RR>20 76% 34% 42.5% 81.3% 
Heart rate 34% 52% 39% - 
        Alt 
conscious 
38% 30% 75% - 
Seizures 4% - - - 
 Common signs were Miosis, Fasciculation and Tachypnoea 
comparable to the studies of Goel et al. 
Comparison of Peradeniya OP Poisoning score and serum CPK level. 
POP score SERUM  CPK Mean + SD 
 Present study Bhattacharyya et al 
0-3 257.23 273.53 
4-7 634.05 456.06 
8-11 997.75 1032.57 
Elevationof serum CPK correlates with severity of POP score. 
Our study was consistant with Bhattacharyya et al study. 
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COMPARISON OF MORTALITY 
STUDY Expired (%) 
Present study 20 
Kamath et al 8 
Manimala et al 13.79 
Johnsen Samuel et al 18.1 
Sundaram et al 23.5 
 
 Mortality in the present study was comparable of the study of 
Sundaram et al 
Peradeniya OP Poisoning scale 
 POP scale was calculated for all patients on admission. 52% of 
patients had mild grade of poisoning, 40% had moderate grade of 
poisoning 8% had severe grade of poisoning. Out of the 20 patients of 
moderate grading 14 patients required ventilatory support. Out of this 14 
patients 7 patients were expired. All 4 of the severe grade of poisoning 
required ventrilatory support. Out of this 4 patients 3 patients expired.                                                                                                                                                                                                
Serum CPK level: 
 Serum CPK level was assessed in all  patients. CPK level range 
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from 128IU/L to 1057 IU/L. Patients with mild POP scoring had range 
from 128IU/L to 344IU/L. Patients with moderate POP scoring had 
ranges from 372IU/L to 994IU/L. POP scoring of severe grade had ranges 
from 978IU/L to 1057 IU/L.    
           From this study we have found that there is a high degree of 
correlation between the POP score and the initial serum creatine 
phosphokinase level. A study conducted by Sharma et al has shown that 
CPK was elevated in a fraction of their cases who had severe poisoning. 
It has been shown that there is rhabdomyolysis in IMS and consequently 
there is raised CPK level. 
      But our study shown that serum CPK level is increased even in 
absence of IMS. 
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CONCLUSIONS 
 OPC poisoning is one of the most common modes of suicidal death 
in our country. In our study age group between 20 to 40 yrs are more 
commonly encountered in poisoning. There is male preponderance in our 
study. Most of the patients consumed poison with a suicidal intension. All 
patients had consumed the poison orally.More than 50% of the patients 
had consumed less than 50ml of poison. Quantity of the poison consumed 
correlate with the severity of poisoning. The most common poisonous 
agent is monocrotophos. There was a good correlation between the 
severity of the POP scale and the elevation of CPK and the need for 
ventilatory support.Peradeniya OP poisoning score more than 5 correlated 
in predicting the need for ventilatory support and mortality. Serum CPK 
level more than 500IU/L correlated in predicting the need for ventilatory 
support and mortality   In this study requirement of  ventilatory support 
was seen in 36% of patients.  Mortality in our study was 20%.We found a 
high degree of correlation between initial CPK and POP score.The 
correlation was found to be highly significant (P<0.000). 
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SUMMARY 
A prospective clinical study was undertaken in 50 patients with a 
history of organophosphate poison ingestion admitted at GMK Medical 
college from June2010 to December 2012.                                                                                            
The objectives of the study were to evaluate the prognostic value 
and correlation of serum CPK with Peradeniya OP poison scale. All 
patients aged between 15 to 65 years without any comormid conditions 
were eligible for this study. 
A thorough clinical examination was carried out with particular 
reference to vital parameters. Pupil size, assessment of CNS system 
,respiratory system, cardiovascular system as per prescribed proforma. 
This examnination  took place during initial resuscitation of the patients. 
Peradeniya OP poisoning scale was applied to all study subjects 
and the severity  of OP poisoning was graded as mild, moderate, severe. 
All patients were manged with decontamination procedure 
including gasric lavage. IV atropine 2-4 mg bolus and repeated every 5-
15 minutes initially until atropinization. The end point of treatment was 
taken as the drying up of secretions. The atropinization was maintained 
for 24-48 hrs with intermittent doses. Pralidoxime chloride was given to 
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all patients as 2g IV bolus over 10-15 minutes immediately after 
admission and 0.5-1g IV 6TH hourly for 48 hrs. Patients were kept under 
observation during their stay in hospital. Assessment of patients airway 
and need for endotracheal intubation was assessed, if nessassory 
ventilatory support given.  
Psychiatric counseling was done for the patients who survived.The 
study revealed all the patients with OP poison ingestion had elevation of 
serum creatine phosphokinase levels correlated with the gradings of the 
Peradeniya OP poisoning scale, and ventilatory requirement. POP scale 
more than 5 and serum CPK level more than 500IU/L were more likely to 
be associated with the development of respiratory failure and subsequent 
requirement of ventilatory support. 
 
 
 
 
 
PROFORMA OF THE STUDY 
1. Name: 
2. Age (yrs) 
3. Sex: M/F 
4. Address: 
 
5. Occupation: 
6. Marital status: 
7. History: 
       a) Nature of OP compound consumed 
      b) Route of consumption 
      c) Quantity consumed 
      d)Time interval from ingestion to hospitalaization 
      e) Homicidal/Suicidal/Accidental 
 
 8. Clinical signs: 
              Miosis 
              Fasciculation 
              Respiration 
              Heart rate 
              Level of consciousness 
9. POP score: 
10. Serum CPK: 
11. Requirement of ventilatory support: 
12. Outcome: 
 
 
 
 
 
ANNEXURE 2: POP scale 
S.NO PARAMETERS SCORE 
PATIENTS 
SCORE 
  Pupil size >2mm 0  
1. Miosis Pupil size <2mm 1  
  Pin Point 2  
  None 0  
2. Fasciculation Present 1  
  Generalized/cyanosis 2  
  <20/min 0  
3. Respiration >20/min 1  
  >20/min & cyanosis 2  
  >60/min 0  
4. Heart rate 41-60/min 1  
  <40/min 2  
  Conscious / alert 0  
5. Level of 
consciousness 
Impaired, responds to 
verbal commands 
1  
  No responds 2  
  Convulsions +1  
 TOTAL  11  
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26 Latchumi 35 F M C O 100 S Monocroto 4 2 1 1 1 1 0 6 928 Y E27 Madhu 65 M M Nw O 30 S Endosulph 3 1 0 0 0 0 0 1 241 N I28 Vadivel 66 M M Nw O 75 S Tic 20 4 2 1 1 1 2 0 7 994 Y E29 Lalitha 30 F M C O 40 S Endosulph 3 1 1 0 0 0 0 2 312 N I30 Selvam 43 M M C O 50 S C+C 2 1 1 1 0 0 0 3 319 N I31 Ishwarya 17 F Um St O 25 S Triazopho 3 1 0 0 0 0 0 1 217 N I32 Muthusa 35 M M C O 50 S Dimethoa 4 1 1 1 0 1 0 4 416 N I33 Revathy 22 F M Hw O 30 S Monocroto 2 1 1 0 0 0 0 2 316 N I34 Sathya 45 F M C O 50 S Triazoph 4 1 1 1 0 0 0 3 344 N I35 Madhesh 21 M Um St O 25 S Monocroto 3 1 1 0 0 0 0 2 274 N I36 Vijayan 35 M M F O 125 S Monocroto 3 2 1 1 1 1 1 7 916 Y E37 Ramasam 55 M M F O 25 S P+E 4 2 1 1 0 0 0 4 520 Y I38 Sarasu 28 F M C O 30 S C+C 2 1 0 1 0 0 0 2 198 N I39 Chinnaya 48 M M F O 30 S Malathion 2 0 0 1 0 0 0 1 174 N I40 Laxshmi 20 F M Hw O 75 S Tic 20 4 2 1 1 1 2 1 8 978 Y E41 Raja 24 M Um St O 25 S P+E 2 1 0 1 0 0 0 2 252 N I42 Jayamma 58 F M C O 50 S Monocroto 3 2 1 1 0 1 0 5 472 Y I43 Menaka 18 F Um Nw O 45 S Dimetho 3 1 1 1 0 0 0 3 294 N I44 Saraswat 38 F M Hw O 25 S P+E 2 1 0 0 0 0 0 1 250 N I45 Karupan 58 M M F O 50 S Monocroto 3 2 1 1 1 0 0 5 448 Y I46 Bhasha 28 M M P O 30 S Dimethoat 4 2 0 0 0 0 0 2 317 N I47 Kumar 34 M M P O 50 S Monocroto 6 2 1 1 1 1 0 6 818 Y E48 Kumaran 18 M Um St O 75 S Monocroto 5 2 1 2 0 1 0 6 915 Y E49 Manikam 54 M M C O 40 S Triazoph 3 1 1 0 0 0 0 2 178 N I50 Kalpana 18 F Um St O 25 S Monocroto 1 0 0 1 0 0 0 1 128 N I
  
KEY TO MASTER CHART 
1. S.NO 
 2. Name 
 3. Age 
 4. Sex – M-Male, F-Female 
 5. Marital status –M-Married, Um-Unmarried 
 6. O-Occupation -St-Student, C- Coolie, P- Private, F-Farmer, Hw 
House wife, Nw-Not working,  
 7. Route of ingestion-O-Oral 
 8. Quantity 
 9. Intention – S-Suicide 
10. Type of poison 
11. Time interval 
12. Miosis 
13. Fasciculation 
14. Respiration 
  
15. Heart Rate 
16. Consciousness 
17. Seizures 
18. Total Score 
19. Serum CPK – Creatine Phosphokinase 
20. Ventilatory support – Yes - Y, No – N 
21. Outcome – I - Improved, E – Expired 
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